ConductScience.org, home

Paper17577015

Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial.

Bartelink H and 11 others. J Clin Oncol, 2007. Cited by 718 papers, by iCite.

Cite this record

ConductScience Library. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. Papers, record 17577015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17577015

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial.
PubMed
Journal
J Clin Oncol
PubMed
Year
2007
PubMed
Publication types
Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
718
iCite
Relative citation ratio, by iCite
19.2
iCite
Revised in PubMed
2022-04-08
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bartelink HHarry
2Horiot JCJean-Claude
3Poortmans PMPhilip M
4Struikmans HHenk
5Van den Bogaert WWalter
6Fourquet AAlain
7Jager JJJos J
8Hoogenraad WJWillem J
9Oei SBS Bing
10Wárlám-Rodenhuis CCCarla C
11Pierart MMarianne
12Collette LLaurence

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Dose Fractionation, RadiationMajor topic
Adult
Combined Modality Therapy
Disease Progression
Disease-Free Survival
Female
Follow-Up Studies
Humans
Mastectomy, Segmental
Middle Aged
Neoplasm Recurrence, Local
Radiotherapy Dosage
Risk Factors
Treatment Outcome

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
2U10-CA11488-36NCI NIH HHSUnited StatesU10CA114883PubMedNIH RePORTER
5R10-CA11488-11NCI NIH HHSUnited StatesR10CA114881PubMedNIH RePORTER
R10CA011488NIHNIH RePORTER
U10CA011488NIHNIH RePORTER

Download CSV of grants

Trials8

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00907868Breast-Conserving Surgery and Whole-Breast Radiation Therapy With or Without Additional Radiation Therapy to the Tumor in Treating Women With Ductal Carcinoma in Situ (BONBIS)BackgroundClinicalTrials.gov
NCT02114086IORT-Boost-Study, Prospective Observational Study for Intraoperative Radiotherapy of the Breast as a BoostBackgroundClinicalTrials.gov
NCT02858934Feasibility Study of Accelerated Preoperative Radiotherapy for Early Breast CancerBackgroundClinicalTrials.gov
NCT02913729Pre- Versus Postoperative Accelerated Partial Breast IrradiationBackgroundClinicalTrials.gov
NCT03077191Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy: a Single Institution ExperienceBackgroundClinicalTrials.gov
NCT04414202Observational Study of Intra-operative Partial Irradiation of Invasive Ductal Breast Carcinomas With a Good PrognosisBackgroundClinicalTrials.gov
NCT06946238Single-fraction APBI for Early-stage Breast Cancer With Favorable Histological Subtypes (Breast-1F)ResultsClinicalTrials.gov
NCT070207805 fr Ultrahypofractionated WBI and SIB for Breast Cancer With Unfavorable CharacteristicsResultsClinicalTrials.gov

Download CSV of trials

Comments and corrections6

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in18089888Enhanced local control by radiation boost in breast cancer: back side of the coin?https://conductscience.org/library/papers/18089888PubMed
Comment in18089889What is the impact of tamoxifen on radiation-induced fibrosis in patients receiving breast-conserving therapy.https://conductscience.org/library/papers/18089889PubMed
Comment in18089890Boost dose back again in elderly.https://conductscience.org/library/papers/18089890PubMed
Comment in18281678Boost or not.https://conductscience.org/library/papers/18281678PubMed
Comment in18640495Radiation-induced side effects with or without systemic therapies: prime time for prediction of individual radiosensitivity.https://conductscience.org/library/papers/18640495PubMed
Comment in21263085More questions about the European Organisation for Research and Treatment of Cancer 22881-10882 boost trial.https://conductscience.org/library/papers/21263085PubMed

Download CSV of comments and corrections

Cited by262

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 718 citations.

PMIDTitleJournalYearIn PapersSource
42783504The Tumor-Bed Boost Irradiation in Early-Stage Breast Cancer 30 Years After the Landmark Trials: What Is New?J Pers Med2026https://conductscience.org/library/papers/42783504PubMed
42604117Transitioning from neoadjuvant chemoradiation to perioperative chemotherapy for esophageal adenocarcinoma: Impact on margins and pathologic outcomes.JTCVS Open2026https://conductscience.org/library/papers/42604117PubMed
42312740Evaluation of 3D-CRT vs. VMAT for radiotherapy of whole breast with simultaneous integrated boost.Acta Oncol2026https://conductscience.org/library/papers/42312740PubMed
42049401Helical Tomotherapy in Local Advanced Breast Cancer Following Mastectomy: Long-term Results and Late Toxicity Analysis.In Vivo2026https://conductscience.org/library/papers/42049401PubMed
41987326Dosimetric comparison of sequential planning (SP) versus bias dose planning (BDP) in volumetric modulated arc therapy (VMAT)-based breast radiotherapy boost.J Appl Clin Med Phys2026https://conductscience.org/library/papers/41987326PubMed
41510712Breast Cancer: Challenges in the Treatment and Prodrug Strategies.Mini Rev Med Chem2026https://conductscience.org/library/papers/41510712PubMed
41491223Distant recurrence and margin involvement in invasive breast cancer.Br J Cancer2026https://conductscience.org/library/papers/41491223PubMed
41485765Reoperation Versus Dose-Escalated Radiotherapy for Ductal Carcinoma In Situ at the Surgical Margin After Breast-Conserving Surgery for Invasive Ductal Carcinoma.J Breast Cancer2025https://conductscience.org/library/papers/41485765PubMed
41007715A Biological-Driven Approach to Explore Dose-Escalated Ultra-Hypofractionation in Breast Cancer Radiotherapy.Biomedicines2025https://conductscience.org/library/papers/41007715PubMed
40914778Preoperative Radiation Boost in Early-Stage Breast Cancer: Effect on Re-excision and Complication Rates.Ann Surg Oncol2025https://conductscience.org/library/papers/40914778PubMed
40837646Clinical comparison of simultaneous integrated and sequential boost IMRT of tumor bed after breast conserving surgery.Afr Health Sci2025https://conductscience.org/library/papers/40837646PubMed
40836156Preoperative Radiation Boost Results in Low Rates of Re-excision and Reduced Locoregional Treatment Time in Breast Cancer Patients.Ann Surg Oncol2025https://conductscience.org/library/papers/40836156PubMed
40708010Optimizing intraoperative radiotherapy as a tumor bed boost with whole-breast irradiation in breast cancer.World J Surg Oncol2025https://conductscience.org/library/papers/40708010PubMed
40699594Long-Term Locoregional Outcomes in a Contemporary Cohort of Young Women With Breast Cancer.JAMA Surg2025https://conductscience.org/library/papers/40699594PubMed
40575221Radiation Recall Phenomenon Following Vaccination in a Patient With Prior Radiation to Lower Extremity Liposarcoma.Cureus2025https://conductscience.org/library/papers/40575221PubMed
40469948Comparison of simultaneous integrated tumor bed boost and sequential boost during hypofractionated whole-breast irradiation after breast-conserving surgery.Clin Transl Radiat Oncol2025https://conductscience.org/library/papers/40469948PubMed
40387868Oncological outcomes of breast cancer patients after planned IORT boost with low-kV x-rays-results of the TARGIT BQR prospective phase IV trial.Strahlenther Onkol2026https://conductscience.org/library/papers/40387868PubMed
40337265
Whole-breast irradiation with lumpectomy cavity boost and regional nodal irradiation: Dosimetric comparison of 3D-CRT using sequential boost and dual partial-arc VMAT using simultaneous integrated boost.
Precis Radiat Oncol2023https://conductscience.org/library/papers/40337265PubMed
40281617Effect of re-excision on local recurrence in patients with involved or close margins after upfront breast-conserving surgery: a systematic review and meta-analysis.World J Surg Oncol2025https://conductscience.org/library/papers/40281617PubMed
40029831Understanding the early molecular changes associated with radiation therapy-A preliminary bulk RNA sequencing study.PLoS One2025https://conductscience.org/library/papers/40029831PubMed

See all 262 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17577015

GET https://conductscience.org/api/papers/v1/17577015/cited_by?page=2